Even so, the results create an important conversation about GLP-1 drugs for heart protection in autoimmune disease
The broader clinical impact must be considered, especially for populations with cardiometabolic disease
Conversely, combining GLP-1 receptor agonists with other diabetes medications like metformin or SGLT2 inhibitors may enhance glucose control
Expansion in obesity management, oral GLP-1 formulations, emerging market penetration, next-generation dual-agonists, and digital health integration offer significant growth opportunities
Layer in automated text/email reminders 48 and 24 hours before appointments, allow easy rescheduling, charge visit fees upfront (creates financial accountability), and foster engagement between visits through apps or coaching check-ins
& Rosenkilde, M